Search Results 981-990 of 15356 for alt

1. A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer - Mayo Clinic

   ... (ALT) and aspartate aminotransferase (AST) ≤ 3 × ULN. If liver metastases are present, AST and ALT ≤ 5 × ULN are acceptable;; renal: serum creatinine ≤ 1.5 ...

2. Safety, Tolerability, and Efficacy of GS 9674 in Adults With Primary Biliary Cholangitis Without Cirrhosis - Mayo Clinic

   Alanine aminotransferase (ALT) > 5 x ULN; Total bilirubin > 2 x ULN; International normalized ratio (INR) > 1.2 unless on anticoagulant therapy; Other causes ...

3. A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma - Mayo Clinic

   ... (ALT) has been set to the value of 45 U/L. * No evidence of dyspnea at rest, no exercise intolerance, and a pulse oximetry \> 94% if there is clinical ...

4. Bendamustine Hydrochloride and Rituximab with or without Bortezomib Followed by Rituximab with or without Lenalidomide in Treating Patients with High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma - Mayo Clinic

   AST and ALT ≤ 5 x upper limit of normal (ULN); Alkaline phosphatase ≤ 5 x ULN; Total bilirubin ≤ 1.5 x ULN (patients with known Gilbert disease should ...

5. A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Management Of Depression - Mayo Clinic

   Hepatic insufficiency (2.5 X ULN for AST or ALT), past liver transplant recipient, and/or clinical diagnosis of cirrhosis of the liver; Malignancy (except ...

6. A Study in Treating Patients With Kidney Cancer Undergoing Nephrectomy Comparing PERioperative Nivolumab vs. Observation - Mayo Clinic

   Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< 2.5 x ULN, within 4 weeks of randomization. No history of severe hypersensitivity to ...

7. A Study of MCLA-128 in Patients with Solid Tumors Harboring an NRG1 Fusion - Mayo Clinic

   ... ALT/AST ≤ 5 x ULN and total bilirubin ≤ 2 x ULN will be allowed; in cases of antecedents of Gilbert's syndrome when total bilirubin ≤ 3.0 x ULN or direct ...

8. Escalating Dose Study in Subjects with Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia - Mayo Clinic

   AST and ALT ≤ 3 × ULN; Platelet count ≥ 50,000/µL (non-hodgkin & Waldenstrom's); Platelet count ≥ 30,000/µL (chronic lymphocytic leukemia); Absolute ...

9. A Study Using the New TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients with Metastatic, Persistent, Recurrent, or Progressive Solid Tumors - Mayo Clinic

   Aspartate transaminase (AST) and alanine aminotransferase (ALT) =< 1.5 x ULN (=< 5 x ULN for patients with liver involvement); Creatinine =< ULN or a ...

10. A Dose Titration Study To Assess The Effects Of SAR407899 In Patients With Microvascular Angina And/or Persistent Stable Angina Despite Angiographically Successful Elective PCI - Mayo Clinic

    ALT >3 times the upper limit of normal (ULN). Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up ...